GGrantIndex
← Leaderboards

Jodie Ann Dionne

University Of Alabama At Birmingham

$7,205,056
Attributed
$16,757,480
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,757,480 · 4

By mechanism

U01$11,918,075 · 1
R01$3,999,733 · 2
K23$839,672 · 1

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Prevalence

Research focus

PrevalenceWomanInfectionEnrollmentUnited StatesResponseAreaInnovationCountryPerinatalPregnancyPreventAntigensBirthPregnant WomenSuccessCameroonInfantAfricaDesignResourcesPathogenesisImmuneRecording Of Previous Events

Grant awards (22)

Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$450,668
R01 · FY2025 · AI · contact PI
Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$159,636
R01 · FY2025 · AI · contact PI
Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$60,596
R01 · FY2025 · AI · contact PI
Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$670,299
R01 · FY2024 · AI · contact PI
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)$351,326
R01 · FY2024 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$2,918,360
U01 · FY2023 · HL
Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$704,567
R01 · FY2023 · AI · contact PI
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)$396,599
R01 · FY2023 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$2,954,063
U01 · FY2022 · HL
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)$403,480
R01 · FY2022 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$2,913,464
U01 · FY2021 · HL
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)$382,769
R01 · FY2021 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$2,863,446
U01 · FY2020 · HL
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)$419,793
R01 · FY2020 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$178,607
U01 · FY2020 · HL
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV$168,156
K23 · FY2020 · HD · contact PI
UAB-MISS MACS/WIHS Combined Cohort Study$59,585
U01 · FY2020 · HL
UAB-MISS MACS/WIHS Combined Cohort Study$30,550
U01 · FY2020 · HL
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV$167,355
K23 · FY2019 · HD · contact PI
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV$167,633
K23 · FY2018 · HD · contact PI
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV$168,264
K23 · FY2017 · HD · contact PI
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV$168,264
K23 · FY2016 · HD · contact PI